Your browser doesn't support javascript.
loading
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis.
Peng, Ling; Qin, Bao-Dong; Xu, Song; Xia, Yang; Yang, Jin-Song; Xiao, Kui; Stebbing, Justin.
Afiliação
  • Peng L; Cancer Center, Department of Pulmonary and Critical Care Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Qin BD; Department of Medical Oncology, Changzheng Hospital, Shanghai, China.
  • Xu S; Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Xia Y; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Yang JS; Department of Radiotherapy, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Xiao K; Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Stebbing J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Oncol Res Treat ; 45(5): 281-290, 2022.
Article em En | MEDLINE | ID: mdl-35114663

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article